The form is not published.
Our Vision: To provide all communities in the developing world with access to accurate, timely, and actionable health information services.
Our Mission: Leveraging artificial intelligence to enhance access and disease monitoring for underserved communities in developing countries.
Galenica is a Joint Venture between Cimpogest, a Mozambican conglomerate in industrial development, healthcare, natural resources and tourism; and Quantilus Innovation, a US company that specializes in developing practical applications using AI.
AI can (and we firmly believe, will) be a force for good. APOIO is the first step towards harnessing its power to bring substantive value to our society.
Bringing healthcare access to underserved and remote communities requires innovative solutions.
APOIO will facilitate healthcare access, offering immediate advice to users and assisting government agencies to manage and prevent disease outbreaks.
Mozambique
A highly connected nation, with an exponentially growing and tech savvy younger generation.
Improving community health benefits wellbeing, lifespan and productivity thereby contribute to economic development.
Bridging information and access gaps in remote and under-serviced areas for the whole family including young children and especially infants, where mortality is particularly high.
Early intervention, reduces the spread of communicable diseases.
Providing critical healthcare information to teenagers and other young people, enabling informed decisions.
Reducing burden on overstretched healthcare systems, freeing medical professionals for areas of greater need.
Data analysis and early warning systems will allow healthcare agencies to develop optimum public health programs.
When APOIO is rolled out, Mozambique will have a core team of trained AI technicians – creating a major boost for the economy.
Providing a national health database that can be integrated with the healthcare system.
